YEM Search

Plant Summary

Plant Information

TCMBank_ID:	TCMBANKHE003919
ID:	TCMBANKHE003919
植物拉丁名:	Medicago sativa
功能与主治:	To clear heat and cool blood, disinhibit damp and abate jaundice./Febrile diseases with vexation and fullness, jaundice, enteritis, dysentery, edema, urethral stone, hematochezia from hemorrhoids.
药用植物名:	苜蓿
药用部位:	whole herb
TCM_ID_id:	5759

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000053	stachydrine	dimethylproline; (-)-Stachydrine; (2S)-2-carboxy-1,1-dimethylpyrrolidinium; proline betaine; (S)-2-carboxy-1,1-dimethylpyrrolidinium; 104622-EP2301932A1; AJ-38211; (2S)-1,1-DIMETHYL-1??-PYRROLIDINE-2-CARBOXYLIC ACID; Prestwick2_000622; SR-05000002246; SCHEMBL578113; (2S)-1,1-dimethylpyrrolidin-1-ium-2-carboxylic acid; BPBio1_000644; 1sw1; 2b4m; Prestwick1_000622; ZINC2528042; SPBio_002803; stachy-drine; BSPBio_000584; SC-20792; AC1L9LTA; CHEBI:44813; Prestwick0_000622; N,N-dimethyl-L-prolinium; 1,1-DIMETHYL-PROLINIUM; SR-05000002246-2; Prestwick3_000622	C7H13NO2	143.18 g/mol	C[N+]1(CCCC1C(=O)[O-])C
TCMBANKIN000102	petunidin	Petunidin 3-O-beta-D-sambubioside; Petunidin 3-sambubioside; petunidin 3-rhamnoglucoside_qt; Petunidin 3-(2-xylosylglucoside); LMPK12010363; petunidin	C16H13O7+	317.27 g/mol	COC1=CC(=CC(=C1O)O)C2=[O+]C3=CC(=CC(=C3C=C2O)O)O
TCMBANKIN000281	Myricadiol	AC1NSYWT; isomyricadiol; myricadiol; (3S,14bR)-8a-(hydroxymethyl)-4,4,6a,6a,11,11,14b-heptamethyl-1,2,3,4a,5,6,8,9,10,12,12a,13,14,14a-tetradecahydropicen-3-ol	C30H50O2	442.72	CC1(CCC2(CC=C3C4(CCC5C(C(CCC5(C4CCC3(C2C1)C)C)O)(C)C)C)CO)C
TCMBANKIN000425	lucernol		C15H8O6	284.22 g/mol	C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=CC(=C(C=C43)O)O
TCMBANKIN000741	canaline	AX8039064; BG00900857; 5415AA; ANW-60615; KB-209864; AJ-51600; FCH874697; D-CANALINE; (R)-2-Amino-4-(aminooxy)butanoic acid; 128395-79-9; UNII-T7H2XP1ZNS; TC-149360; CTK4B5934; SCHEMBL440858; DTXSID80436383; ZINC4535965; AK-88063; T7H2XP1ZNS	C4H10N2O3	134.13 g/mol	C(CON)C(C(=O)O)N
TCMBANKIN002962	onopordopicrin		C19H24O6	348.4 g/mol	CC1=CCCC(=CC2C(C(C1)OC(=O)C(=C)CO)C(=C)C(=O)O2)CO
TCMBANKIN008647	delta-Carotene	472-92-4; (6R)-6-[(1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaenyl]-1,5,5-trimethyl-cyclohexene; (6R)-6-[(1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaenyl]-1,5,5-trimethylcyclohexene; delta-carotene; C08586; LMPR01070266	C40H56	536.87	CC1=CCCC(C1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C)C)C)(C)C
TCMBANKIN010014	7-o-β-d-glucuronopyranosyl-4'-o-[2'-o-e-feruloyl-o-β-d-glucuronopyranosyl(1→2)-o-β-d-glucuronopyranoside]apigenin		C43H42O26
TCMBANKIN012700	coumestrol	NCIMech_000078; CCRIS 7311; A-Lactone; API0002121; Tox21_200032; MolPort-003-846-031; US8552057, 3; HMS3374A07; 3,9-Dihydroxy-6H-benzofuro[3,2-c]-[1]benzopyran-6-one; 6H-Benzofuro[3,2-c][1]benzopyran-6-one,3,9-dihydroxy-; Cumostrol; CHEBI:3908; C-16836; VZ31590; LS-35394; S00280; 3,9-dihydroxy-[1]benzofuro[3,2-c]chromen-6-one; MFCD00016885; SMP2_000163; DSSTox_RID_76572; 27885_FLUKA; 6H-Benzofuro[3, 3,9-dihydroxy-; 5-19-06-00405 (Beilstein Handbook Reference); BRN 0266702; 479-13-0; NSC22842; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, delta-lactone; C10205; 3,9-dihydroxy-[1]benzoxolo[3,2-c]chromen-6-one; AC1NQYXV; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, delta-lactone (6CI); NCGC00018124-01; DSSTox_CID_2399; CTK8F8799; Coumestrol, >=95.0% (HPLC); NCI60_001863; 4CN-2508; ZZIALNLLNHEQPJ-UHFFFAOYSA-N; BIDD:ER0114; NCGC00018124-03; 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one #; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-; A1-00298; NSC 22842; 3,9-Dihydroxy-6H-benzofuro(3,2-c)(1)benzopyran-6-one; CCG-35536; NCGC00018124-06; 3,9-bis(oxidanyl)-[1]benzofuro[3,2-c]chromen-6-one; ZINC1219; NCGC00257586-01; 3,9-Dihydroxy-benzo[4,5]furo[3,2-c]chromen-6-one; AIDS011954; SCHEMBL22012; UNII-V7NW98OB34; 3-Benzofurancarboxylic acid, 2-(2,4-dihydroxyphenyl)-6-hydroxy-, .delta.-lactone; 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-; MLS000069446; CCG-36200; LMPK12090018; 3-Benzofurancarboxylic acid,4-dihydroxyphenyl)-6-hydroxy-, .delta.-lactone; 7,12-Dihydroxycoumestan; CS-6343; D02DML; CHEMBL30707; 3,9-dihydroxy-6-benzofurano[3,2-c]chromenone; ZINC00001219; 5,14-dihydroxy-8,17-dioxatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),2,4,6,11(16),12,14-heptaen-9-one; Oprea1_222511; MLS000738006; EINECS 207-525-6; 3,9-Dihydroxycoumestan; Coumestrol, BioReagent, suitable for fluorescence, >=97.5% (HPLC); A827386; DTXSID6022399; CAS-479-13-0; FT-0603177; ST50320052; 2-(2,4-Dihydroxyphenyl)-6-hydroxy-3-benzofurancarboxylic Acid ; 3,9-dihydroxybenzofurano[3,2-c]chromen-6-one; 3,9-dihydroxybenzo[d]chromeno[4,3-b]furan-6-one; NCGC00023462-03; AIDS-011954; V0359; Cumoestrol; DSSTox_GSID_22399; Cumoesterol; NCGC00018124-05; Coumestrol; NCGC00018124-04; V7NW98OB34; ZB000278; 3,9-Dihydroxy-6H-[1]benzofuro[3,2-c]chromen-6-one; ST5320052; AN-6463; Cumestrol; NCGC00023462-04; NCGC00018124-02; CC-25990; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihdyroxy-; NSC-22842; 3,9-dihydroxybenzofuro[3,2-c]chromen-6-one; AKOS028111776; HMS2235B05; Coumesterol; COUMESTROL; BDBM23451; SMR000059001; HY-N2335; 27883_FLUKA	C15H8O5	268.22	C1=CC2=C(C=C1O)OC3=C2C(=O)OC4=C3C=CC(=C4)O
TCMBANKIN015370	malvidin	malvidin ; Malvidin-3,5-diglucoside_qt	C17H15O7+	331.3 g/mol	COC1=CC(=CC(=C1O)OC)C2=[O+]C3=CC(=CC(=C3C=C2O)O)O
TCMBANKIN015465	petunidin-3-arabinoside		C21H21ClO11	484.8 g/mol	COC1=CC(=CC(=C1O)O)C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(CO4)O)O)O)O)O.[Cl-]
TCMBANKIN015826	sativol	AC1MJ1Q2; 8,12-Dihydroxy-7-methoxycoumestan; DTXSID10223546; Sativol; LMPK12090036; 4,9-Dihydroxy-3-methoxycoumestan; 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 4,9-dihydroxy-3-methoxy-; 4,9-dihydroxy-3-methoxy-[1]benzofuro[3,2-c]chromen-6-one; 7331-58-0; 4,9-Dihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one	C16H10O6	298.25 g/mol	COC1=C(C2=C(C=C1)C3=C(C4=C(O3)C=C(C=C4)O)C(=O)O2)O
TCMBANKIN016653	formononetin-7-glucoside		C22H22O9	430.4 g/mol	COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C=C3)OC4C(C(C(C(O4)CO)O)O)O
TCMBANKIN019256	medicagol	3-Hydroxy-6H-[1,3]dioxolo[5,6]benzofuro[3,2-c][1]-benzopyran-6-one, 9CI; UNII-5OBT39CCC9; BG01008083; AK687091; 16-HYDROXY-5,7,11,19-TETRAOXAPENTACYCLO[10.8.0.0(2),(1)?.0?,?.0(1)(3),(1)?]ICOSA-1(12),2(10),3,8,13(18),14,16-HEPTAEN-20-ONE; 5OBT39CCC9; 7-Hydroxy-11,12-methylenedioxycoumestan; Medicagol; 3-Hydroxy-8,9-methylenedioxycoumestan; LMPK12090025; SCHEMBL74591; CHEMBL99941; 1983-72-8; DTXSID10173557; 6H-(1,3)Dioxolo(5,6)benzofuro(3.2-c)(1)benzopyran-6-one, 3-hydroxy-; ZINC2561256; 7-Hydroxy-5',6'-methylenedioxybenzofurano[3',2':3,4]coumarin; AKOS032946033; 3-Hydroxy-6H-[1,3]dioxolo[4',5':5,6]benzofuro[3,2-c]chromen-6-one	C16H8O6	296.23 g/mol	C1OC2=C(O1)C=C3C(=C2)C4=C(O3)C5=C(C=C(C=C5)O)OC4=O
TCMBANKIN019824	canavalia gibberellin i		C19H22O7	362.4 g/mol	C=C1CC23CC1(CCC2C45CCCC(C4C3C(=O)O)(C(=O)O5)C(=O)O)O
TCMBANKIN021214	suchilactone	SCHEMBL15624884	C21H20O6	368.38	COC1=C(C=C(C=C1)CC2COC(=O)C2=CC3=CC4=C(C=C3)OCO4)OC
TCMBANKIN022981	coumingidine	[(2S,4aR,7Z)-1,1,4a,8-tetramethyl-7-[3-(methylamino)propanoyloxymethylidene]-9-oxo-2,3,4,4b,5,6,8,8a,10,10a-decahydrophenanthren-2-yl] 3-hydroxy-3-methylbutanoate; AC1NSTWP	C25H39NO5	433.6 g/mol	CC1C2C(CCC1=CC(=O)OCCNC)C3(CCC(C(C3CC2=O)(C)C)OC(=O)C)C
TCMBANKIN025581	4-o-8',5'-5''-dehydrotriferulicacid		C30H26O12
TCMBANKIN025631	medicagenic acid 3-o-triglucoside	medicagenicacid 3-o-triglucoside	C48H76O21	989.1 g/mol	CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)C(=O)O)OC6C(C(C(C(O6)CO)O)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)O)O)C)C)C2C1)C)C(=O)O)C
TCMBANKIN025650	delphin	Delphin; SCHEMBL318115; LMPK12010283; DELPHIN	C27H31O17+	627.5 g/mol	C1=C(C=C(C(=C1O)O)O)C2=C(C=C3C(=CC(=CC3=[O+]2)O)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O
TCMBANKIN026229	delphindin		C15H11O7		C1=C(C=C(C(=C1O)O)O)C2=C(C=C3C(=CC(=CC3=[O+]2)O)O)O
TCMBANKIN027702	Citrusin B	SCHEMBL7641595; 3-[3-Methoxy-4-[(beta-D-glucopyranosyl)oxy]phenyl]-2-[2,6-dimethoxy-4-[(E)-3-hydroxy-1-propenyl]phenoxy]-1,3-propanediol; citrusin B; citrusin b; 105279-10-5	C27H36O13	568.57	COC1=CC(=CC(=C1OC(CO)C(C2=CC(=C(C=C2)OC3C(C(C(C(O3)CO)O)O)O)OC)O)OC)C=CCO
TCMBANKIN030208	daidzein 4',7-diglucoside		C27H30O14	578.5 g/mol	C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)O)OC5C(C(C(C(O5)CO)O)O)O
TCMBANKIN030511	l-arginine	(2S)-N-[(1S)-1-[[(1S)-1-(acetylcarbamoyl)-4-guanidino-butyl]carbamoyl]-4-guanidino-butyl]-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-[[(2S)-5-guanidino-2-hydroxy-pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanamide	C56H112N36O11	1465.7 g/mol	CC(=O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)O
TCMBANKIN035087	malvidin-3-arabinoside		C22H23ClO11	498.9 g/mol	COC1=CC(=CC(=C1O)OC)C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(CO4)O)O)O)O)O.[Cl-]
TCMBANKIN036261	3-o-[beta-d-galactopyranosyl-(1-2)-beta-d-glucuronopyranosyl]-28-o-[beta-d-glucopyranosyl-(1-2)-alpha-l-rhamnopyranosyl-(1-2)-beta-d-4-o-trans-p-methoxycinnamoyl-fucopyranosyl] quillaic acid		C76H116O26
TCMBANKIN036832	daidzein	486-66-8; AIDS-059333; ST057515; KBio2_005871; CCRIS 7600; 7-Hydroxy-3-(4-hydroxy- phenyl)- chromone; SPBio_000205; AIDS059333; 4′,7-Dihydroxy- iso- flavone; nchembio.2007.28-comp31; KBio2_003303; Spectrum3_000191; Isoflavone, 4',7-dihydroxy- (8CI); Oprea1_182317; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; Spectrum5_000857; NCGC00025156-01; BiomolKI_000060; S00273; NCGC00015365-01; KBio1_001023; BiomolKI2_000066; KBioSS_000735; Daidzeol; SMP1_000089; 7,4'-Dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; C10208; SPECTRUM200789; nchembio.76-comp16; BSPBio_001741; NCGC00025156-09; Daidzein (6CI); 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; BRN 0231523; 5-18-04-00089 (Beilstein Handbook Reference); Daidzein; Daidzein (4',7-Dihydroxyisoflavone); KBioGR_002432; NINDS_001023; KBio2_000735; ACon1_000543; NCGC00025156-07; ZINC00047551; daidzein ; NCGC00025156-02; Lopac-D-7802; Tocris-1417; 7-hydroxy-3-(4-hydroxyphenyl)chromone; ACon0_001477; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone; KBio3_001241; DivK1c_001023; Spectrum4_001964; K 251b; UPCMLD-DP052:001; IDI1_001023; MEGxm0_000123; Lopac0_000412; D7802_SIGMA; Spectrum2_000053; EINECS 207-635-4; Spectrum_000255; 4′,7-Dihydroxyisoflavone; NCGC00025156-05; 4',7-Dihydroxy-iso-flavone; NCGC00025156-04; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4-chromenone; 7-Hydroxy-3-(4-hydroxy- phenyl)-4H-1-benzo- pyran-4-one; EU-0100412; CHEBI:28197; SDCCGMLS-0066422.P001; 4',7-Dihydroxyisoflavone; Oprea1_305345	C15H10O4	254.238	c1([H])c(C(=O)C(c2c([H])c([H])c(O[H])c([H])c2[H])=C([H])O3)c3c([H])c(O[H])c1[H]
TCMBANKIN038032	formononetin	Oprea1_815287; AIDS027672; 7-hydroxy-3-(4-methoxyphenyl)-4H-benzopyran-4-one; Isoflavone, 7-hydroxy-4'-methoxy- (8CI); NCI60_042081; NCGC00095207-03; Oprea1_139748; NCIOpen2_005983; SDCCGMLS-0066428.P001; CHEBI:18088; TNP00176; 485-72-3; Formononetol; Isoflavone, 7-hydroxy-4'-methoxy-; 7-hydroxy-3-(4-methoxyphenyl)chromone; Spectrum2_000560; Formononetin; NSC 93360; EINECS 207-623-9; 47752_FLUKA; KBio2_000853; 7-Hydroxy-3-(4-methoxyphenyl)-4-benzopyrone; Spectrum5_000258; KBio3_001519; NSC93360; KBioSS_000853; Spectrum_000373; SPECTRUM102007; KBio2_005989; Biochanin B; KBioGR_001878; NCGC00017269-01; 7-Hydroxy-3-(4′-methoxyphenyl)-4H-benzopyran-4-one; formononetin ; 7-hydroxy-4'-methoxy-isoflavone; BSPBio_002299; ZINC00113304; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)- (9CI); SBB016445; Spectrum3_000660; 7-hydroxy-3-(4-methoxyphenyl)-4H-chromen-4-one; Spectrum4_001429; DivK1c_006319; KBio2_003421; SPBio_000639; NCGC00095207-01; KBio1_001263; AIDS-027672; 7-Hydroxy-4'-methoxyisoflavone; C00858; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-methoxyphenyl)-; NCGC00095207-02; SpecPlus_000223	C16H12O4	268.264	C1([H])=C(c2c([H])c([H])c(OC([H])([H])[H])c([H])c2[H])C(c3c(O1)c([H])c(O[H])c([H])c3[H])=O
TCMBANKIN038143	stachyose	O-alpha-D-galactopyranosyl-(1->6)o-alpha-D-galactopyranosyl-(1->6)O-alpha-D-galactopyranosyl-beta-D-fructofuranoside; 10094-58-3; C01613; Stachyose; beta-D-fructofuranosyl alpha-D-galactopyranosyl-(1->6)-alpha-D-galactopyranosyl-(1->6)-alpha-D-glucopyranoside; 470-55-3; alpha-D-Galp-(1->6)-alpha-D-Galp-(1->6)-alpha-D-Glcp-(1<->2)-beta-D-Fruf; (2R,3R,4S,5S,6R)-2-[[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)-2-tetrahydrofuranyl]oxy]-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxymethyl]-2-tetrahydropyranyl]oxymethyl]tet; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetra; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-dimethylol-tetrahydrofuran-2-yl]oxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-3,; CHEBI:17164	C24H42O21	667	O([H])[C@]1([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(OC([H])([H])[C@]2([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(O[C@]3([H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H] )O[H])O[C@]3([H])O[C@]4([C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)C([H])([H])O[H])O2)O[C@]1([H])C([H])([H])O[H]
TCMBANKIN040831	tricin	NSC294579; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-chromenone; AIDS-120640; 3',5'-O-dimethyltricetin; CHEBI:60016; 3',5'-di-O-methyltricetin(1-); 5,7,4-trihydroxy-3, 5-dimethoxyflavone; 3',5'-di-O-methyltricetin; 520-32-1; Tricetin 3',5'-di-methyl ether; Tricin; C10193; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-4-one; 5,7-Dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-1-benzopyran-4-one; AIDS120640; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)chromen-4-one; NSC 294579; 4',5,7-trihydroxy-3',5'-dimethoxyflavone; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)chromone; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-oxo-4H-chromen-7-olate	C17H14O7	330.289	c1(O[H])c(OC([H])([H])[H])c([H])c(C2=C([H])C(=O)c3c(c([H])c(O[H])c([H])c3O[H])O2)c([H])c1OC([H])([H])[H]
TCMBANKIN043132	beta-methyl-d-glucoside	.beta.-d-Methylglucopyranoside; Methyl b-D-glucopyranoside; (2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol; DB-055468; 709-50-2; FT-0628705; 75398-85-5; 7804AF; NSC 403457; beta-d-Methylglucopyranoside; CHEMBL132186; methyl beta-(D)-glucopyranoside; UNII-54L5T38NI8 component HOVAGTYPODGVJG-XUUWZHRGSA-N; CM-1331; Methyl beta-d-glucopyranoside hemihydrate; Methyl .beta.-D-glucoside; beta-Methyl-D-glucoside hemihydrate; CHEBI:320055; 27939-29-3; BG01510468; KS-000007XU; DB01642; beta-Methylglucoside; Glucopyranoside, methyl, .beta.-D-; Methyl beta-D-glucopyranoside, >=99% (HPLC and GC); M0779_SIGMA; EINECS 211-909-9; BIM8001; Methyl-beta-D-glucopyranoside hemihydrate, >=99.0% (sum of enantiomers, HPLC); Methyl b-D-glucopyranoside hemihydrate; TL8006618; 1-O-Methyl-beta-D-glucopyranoside; Epitope ID:149560; beta-Methyl-D-glucoside; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol; 30326-25-1; 7000-27-3; SCHEMBL166332; MGL; 709-50-2 Methyl beta-d-glucopyranosi de; METHYL ?-D-GLUCOSIDE; C-30724; M0709; FT-0628867; MFCD00149442; O1-Methyl-Glucose; HT1198; 1-O-methyl-beta-D-glucopyranose; W-200489; AJ-49843; Methyl beta-D-glucoside hydrate; 1-O-Methyl-.beta.-D-glucopyranoside; Methyl beta-D-glucopyranoside; GC7084; β-methyl-d-glucoside; b-methyl-D-glucoside; 97-30-3; methyl -d-glucopyranoside; Methyl beta-D-glucoside; CC-30725; FCH920155; Methyl-alpha-D-glucopyranoside; Me-ss-Glc; ZX-AFC000308; .beta.-Methyl-(d)-glucoside; AKOS006343694; Methyl b-D-glucoside; beta-D-Glucopyranoside, methyl; HOVAGTYPODGVJG-XUUWZHRGSA-N; Methyl-b-D-glucopyranoside hemihydrate; AK481297; ZINC4262103; Methyl--D-glucoside hemihydrate; MFCD00006602; Methyl-beta-D-glucoside; Methyl .beta.-D-glucopyranoside; Methyl-beta-D-glucopyranoside; methyl-beta-D-glucopyranoside hemihydrate; AC1L9HNF	C7H14O6	194.18 g/mol	COC1C(C(C(C(O1)CO)O)O)O
TCMBANKIN045993	7-O-β-D-Glucuronopyranosyl-4'-O-[2'-O-p-E-coumaroyl-O-β-D-glucuronopyranosyl(1→2)-O-β-D-glucuronopyranoside]apigenin
TCMBANKIN046023	7alpha,21S,25-Trihydroxy-3beta-acetoxy-21S,23R-epoxy-9(11)-en-dammarane	[(3S,8S,10S)-7-hydroxy-17-[(2S,5R)-2-hydroxy-5-(2-hydroxy-2-methylpropyl)oxolan-3-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,12,13,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate; AC1NT14F; 7α,21s,25-trihydroxy-3β-acetoxy-21s,23r-epoxy-9(11)-en-dammarane; 7alpha,21s,25-trihydroxy-3beta-acetoxy-21s,23r-epoxy-9(11)-en-dammarane	C32H52O6	532.84	C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(=C([H])C([H])([H])[C@]([H])([C@@]([H])([C@]2([H])[C@@]([H])(O[H])O[C@@]([H])(C([H])([H])C(O[H])(C([H])([H])[H])C([H])([H])[H])C2([H])[H])C([H])([H])C3([H] )[H])[C@@]34C([H])([H])[H])[C@@]4(C([H])([H])[H])[C@]([H])(O[H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])OC(=O)C([H])([H])[H]
TCMBANKIN057935	D-sedoheptulose	(3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one; CHEBI:16802; D-Altro-2-heptulose; D-altro-hept-2-ulose;l-galactoheptulose;d-mannoheptulose;Sedoheptulose; (3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one; D-Sedoheptulose, >=95% (TLC); ZINC8579422; altro-Heptulose; 40A0W1XJ6X; UNII-40A0W1XJ6X; AC1NUSHL; SCHEMBL119427; CHEBI:16802; D-altro-hept-2-ulose; D-Altro-2-heptulose; 3019-74-7;L-Galactoheptulos; D-Sedoheptulose, >=95% (TLC); ZINC8579422; altro-Heptulose; 40A0W1XJ6X; UNII-40A0W1XJ6X; D-Mannoheptulose; AC1NUSHL; SCHEMBL119427; CHEBI:16802; D-altro-hept-2-ulose; D-Altro-2-heptulose; 3019-74-7	C7H14O7	210.18 g/mol	C(C(C(C(C(C(=O)CO)O)O)O)O)O
TCMBANKIN057963	succinic acid	NCGC00159372-02; AIDS017693; Bernsteinsaure; succ; nchembio856-comp9; SIN; Butanedioic acid diammonium salt; InChI=1/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8; Bernsteinsaeure; ST5213944; nchembio.2007.47-comp2; 4-02-00-01908 (Beilstein Handbook Reference); 623158-99-6; LMFA01170043; BRN 1754069; butanedioic acid; Succinic acid (8CI); acide butanedioique; Dihydrofumaric acid; Katasuccin; 110-15-6; WLN: QV2VQ; FMR; AI3-06297; EINECS 203-740-4; Kyselina jantarova [Czech]; Amber acid; 398055_SIAL; 1,4-Butanedioic acid; S3674_SIAL; succinicacid; Ethylene dicarboxylic acid; 1,4-BUTANEDIOIC ACID (SUCCINIC ACID); S7501_SIAL; NSC25949; Bernsteinsaure [German]; acide succinique; NSC 106449; HOOC-CH2-CH2-COOH; Butandisaeure; 1,2-Ethanedicarboxylic acid; Acidum succinicum; Asuccin; C00042; Wormwood acid; ethylenesuccinic acid; Wormwood; 14078_FLUKA; Butanedionic acid; NSC106449; W502707_ALDRICH; W502715_ALDRICH; NCGC00159372-03; AIDS-017693; spirit of amber; A 12084; CHEBI:15741; Butanedioic acid (9CI); S9512_SIGMA; 14079_FLUKA; HSDB 791; Amber acid; amber acid	C4H6O4	118.09 g/mol	C(CC(=O)O)C(=O)O
TCMBANKIN057966	CIR	C00327; EINECS 206-759-6; (2S)-2-amino-5-(carbamoylamino)pentanoic acid; (2S)-2-amino-5-ureidopentanoic acid; C7629_SIGMA; (2S)-2-amino-5-ureido-pentanoic acid; Citrulline, L-; alpha-Amino-delta-ureidovaleric acid; NSC 27425; (2S)-2-amino-5-(aminocarbonylamino)pentanoic acid; Ornithine, N5-(aminocarbonyl)-; N5-(Aminocarbonyl)ornithine; Ornithine, N5-carbamoyl-, L- (8CI); N(5)-(aminocarbonyl)-L-ornithine; SBB012374; N(delta)-Carbamylornithine; N(5)-carbamoyl-L-ornithine; (2S)-2-amino-5-ureido-valeric acid; (S)-2-Amino-5-ureidopentanoic acid; SMP1_000146; 2-Amino-5-ureidovaleric acid; NCGC00142602-01; L-2-Amino-5-ureidovaleric acid; delta-Ureidonorvaline; CHEBI:16349; citrulline; AB1007188; AC1LCUKE; d-citrullin; AK-58500; (R)-2-Amino-5-ureidopentanoic acid; MFCD00216469; KB-49607; D-Citruline; AX8031821; D-Ornithine,N5-(aminocarbonyl)-; W-204205; H-D-Orn(carbamoyl)-OH; (2R)-5-(aminocarbonylamino)-2-azanyl-pentanoic acid; DTXSID90348463; MolPort-003-928-964; 594C519; H-D-Cit-OH; D-Citrulline, >=99.0%; CTK4C0068; N(5)-carbamoyl-D-ornithine; AmbotzHAA1014; AJ-33795; AB0012765; ST24035348; ACM13594520; D-Citrulline; A807006; PubChem17499; TC-108738; J-300336; CHEBI:49007; SC-10122; C6H13N3O3; SCHEMBL437142; ANW-19993; AM82460; AS-12983; GTPL4683; ZINC2166829; FT-0659369; 13594-51-9; B-7191; D0V2DT; (2R)-2-amino-5-(carbamoylamino)pentanoic acid	C6H13N3O3	175.19 g/mol	C(CC(C(=O)O)N)CNC(=O)N
TCMBANKIN058004	trigonelline	Prestwick_70; N-Methylnicotinic acid betaine hydrochloride; 1-methyl-3-pyridin-1-iumcarboxylate hydrochloride; MFCD00077250; SCHEMBL468365; A833196; trigonelline ; trigonelline HCl; 1-methylpyridin-1-ium-3-carboxylate hydrochloride; AC1O4WFS; 1-Methylpyridinium-3-carboxylate hydrochloride; T-6500; CHEMBL489961; trigonellin; gynesine; trigonelline	C7H7NO2	137.14 g/mol	C[N+]1=CC=CC(=C1)C(=O)[O-]
TCMBANKIN058229	daidzein	Daidzei; 486-66-8; AIDS-059333; ST057515; KBio2_005871; CCRIS 7600; 7-Hydroxy-3-(4-hydroxy- phenyl)- chromone; SPBio_000205; AIDS059333; 4′,7-Dihydroxy- iso- flavone; nchembio.2007.28-comp31; KBio2_003303; Spectrum3_000191; Isoflavone, 4',7-dihydroxy- (8CI); Oprea1_182317; 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one; Spectrum5_000857; NCGC00025156-01; BiomolKI_000060; S00273; NCGC00015365-01; KBio1_001023; BiomolKI2_000066; KBioSS_000735; Daidzeol; SMP1_000089; 7,4'-Dihydroxyisoflavone; 7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone; C10208; SPECTRUM200789; nchembio.76-comp16; BSPBio_001741; NCGC00025156-09; Daidzein (6CI); 4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-; BRN 0231523; 5-18-04-00089 (Beilstein Handbook Reference); Daidzein; Daidzein (4',7-Dihydroxyisoflavone); KBioGR_002432; NINDS_001023; KBio2_000735; ACon1_000543; NCGC00025156-07; ZINC00047551; daidzein ; NCGC00025156-02; Lopac-D-7802; Tocris-1417; 7-hydroxy-3-(4-hydroxyphenyl)chromone; ACon0_001477; 7-Hydroxy-3-(4-hydroxy-phenyl)-chromone; KBio3_001241; DivK1c_001023; Spectrum4_001964; K 251b; UPCMLD-DP052:001; IDI1_001023; MEGxm0_000123; Lopac0_000412; D7802_SIGMA; Spectrum2_000053; EINECS 207-635-4; Spectrum_000255; 4′,7-Dihydroxyisoflavone; NCGC00025156-05; 4',7-Dihydroxy-iso-flavone; NCGC00025156-04; 7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; 7-hydroxy-3-(4-hydroxyphenyl)-4-chromenone; 7-Hydroxy-3-(4-hydroxy- phenyl)-4H-1-benzo- pyran-4-one; EU-0100412; CHEBI:28197; SDCCGMLS-0066422.P001; 4',7-Dihydroxyisoflavone; Oprea1_305345	C15H10O4	254.24	C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O
TCMBANKIN058365	dicoumarin	SBI-0051343.P003; DSSTox_RID_76296; Kumoran; AS-19619; Z57170530; KBio2_000645; BSPBio_000890; Dicumarolo; 3,3'-Metilen-bis(4-idrossi-cumarina); Prestwick_90; LS-55258; NC 034; 3,3''''''''-methylenebis(4-hydroxy-coumarin; 4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one; Spectrum3_000387; 3,3'-Methylenebis[4-hydroxy-2H-1-benzopyran-2-one]; 2H-1-Benzopyran-2-one],3'-methylenebis[4-hydroxy-; AC1L19PT; 3,3'-methanediylbis(4-hydroxy-2H-chromen-2-one); C00796; DSSTox_GSID_21729; Bio-0616; CHEMBL43154; Coumarin, 3,3'-methylenebis[4-hydroxy- (8CI); AB00051966_05; Prestwick0_000785; CHEBI:4513; Antitrombosin; STK801287; AC1Q699Q; UNII-7QID3E7BG7; Cumid; HMS502M18; Dwukumarol; D02TJS; 4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one; 3,3'-Methylenebis[4-hydroxy-1,2-benzopyrone]; DOBMPNYZJYQDGZ-UHFFFAOYSA-N; Prestwick3_000785; H2893; Spectrum_000165; HMS1570M12; 3,3'-Methylene-bis(4-hydroxycoumarin); bis-hydroxycoumarin; NCGC00016296-04; Dicoumarolum [INN-Latin]; SPBio_000248; MFCD00006857; 5-19-06-00682 (Beilstein Handbook Reference); 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one); 3,2-benzopyrone]; Pharmakon1600-01500239; NCGC00094650-02; 3,3'-Methylene-bis(4-hydroxycoumarin), 99%; NSC-17860; Dicumol; CHEMBL1466; CTK5C5178; Temparin; GTPL6808; KBio2_003213; VZ31493; Dicumarol [INN-Spanish]; NSC17860; 3,3'-Methylene-bis(4-hydroxycoumarine) [French]; MolPort-000-422-589; Coumarin, 3,3'-methylenebis[4-hydroxy-(8CI); W-203471; Cuma; IDI1_000896; NCGC00016296-02; 3,3'-Methyleen-bis(4-hydroxy-cumarine); 3,3'-Methyleen-bis(4-hydroxy-cumarine) [Dutch]; HY-N0645; 3,3′-Methylenebis(4-hydroxycoumarin); MCULE-8095183287; SCHEMBL33892; HMS2091M10; 3,3'-methylenebis(4-hydroxy-2H-chromen-2-one); Dicumarol, United States Pharmacopeia (USP) Reference Standard; Dicumarolum; Dicumarolo [DCIT]; 3,3''''''''-methylenebis(4-hydroxycoumarin); NCGC00094650-01; 3,3'-Methylene-bis(4-hydroxycoumarine); SPBio_002829; NSC 41834; Di-4-hydroxy-3,3'-methylenedicoumarin; 2H-1-Benzopyran-2-one,3'-methylenebis[4-hydroxy-; Prestwick1_000785; FT-0624734; NCGC00016296-03; NINDS_000896; DivK1c_000896; Dicumarinum; Di-(4-hydroxy-3-coumarinyl)methane; SR-05000001605; 3,3'-Metilen-bis(4-idrossi-cumarina) [Italian]; CCG-34550; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy-; NSC 221570; SR-05000001605-1; Dufalone; EINECS 200-632-9; Dicoumarol; NCGC00016296-01; Trombosan; HMS1920E20; Dicoumarol (INN); Tox21_110357; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-(9CI); 3,3'-Methylene-bis[4-hydroxycoumarin]; Dicumarol [USAN]; NCGC00016296-07; ChemDiv2_003436; 3,3'-methylenebis(2-hydroxy-4h-chromen-4-one); M0216; Apekumarol; Dicoumal; SPECTRUM1500239; AI3-14546; KBioGR_001055; DB00266; 3,3'-Methylen-bis(4-hydroxy-cumarin); 66-76-2; I14-52299; 4,4'-Dihydroxy-3,3'-methylene bis coumarin; BSPBio_002173; Oprea1_150990; SR-05000001605-3; Dicumarol (TN); BBL008904; BPBio1_000980; HMS3714M12; NSC756733; BG01624449; KBioSS_000645; BRD-K82236179-001-05-0; melitoxin; 3,3 -Methylene-bis[4-hydroxycoumarin]; NCGC00016296-05; Coumarin,3'-methylenebis[4-hydroxy-; Dwukumarol [Polish]; Acavyl; Spectrum4_000508; 3,3-Methylene-bis[4-hydroxycoumarin]; AK325302; Bis(4-hydroxycoumarin-3-yl)methane; D03798; Dicumarol (USAN); dicoumarol; Dikumarol; 2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-; KBio3_001393; SR-05000001605-4; DSSTox_CID_1729; Baracoumin; 2-hydroxy-3-[(2-hydroxy-4-oxochromen-3-yl)methyl]chromen-4-one; CAS-66-76-2; Dicumarol [USAN:USP]; CBDivE_003005; BDBM35525; Tox21_110357_1; NSC-756733; 3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone); Dicuman; Acadyl; 4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-2H-chromen-2-one; SCHEMBL33891; Dicumaol R; 4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one; WLN: T66 BOVJ EQ D1- DT66 BOVJ EQ; NSC 17860; Dicoumarol [INN]; KBio1_000896; Dicoumerol; 3,3'-Methylen-bis(4-hydroxy-cumarin) [German]; NSC221570; Dicumarine; BRN 0335444; Spectrum5_000871; Bis-3,3'-(4-hydroxycoumarinyl)methane; dicumarol; Coumarin, 3,3'-methylenebis(4-hydroxy-; CCRIS 3713; 7QID3E7BG7; KBio2_005781; Y1603; 2H-1-Benzopyran-2-one), 3,3'-methylenebis(4-hydroxy-; CS-7962; Dicoumarolum; HSDB 3223; Prestwick2_000785; 3,3''''''''-methylenebis[4-hydroxycoumarin; DTXSID8021729; s4299; 3,3'-Methylenebis(4-hydroxycoumarin); ZINC3869855; 2H-1-Benzopyran-2-one,3,3'-methylenebis[4-hydroxy-; C19H12O6; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (9CI); 3,3'-Methylenebis[4-hydroxycoumarin]; Anathrombase; NSC41834; 3,3′ HMS3652P10; BG00665451; symmetric dicoumarol analogue, 1; AKOS000520650; Bis-3,3'-(4-oxycoumarinyl)ethylacetate; HMS1378M04; HMS2097M12; 2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-; uncoupler of oxidative respiration; Spectrum2_000144; Bishydroxycoumarin;dicoumarol	C19H12O6	336.3 g/mol	C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O
TCMBANKIN058387	lucidin	lucidin;Henine;1,3-dihydroxy-2-methylol-9,10-anthraquinone; Lucidin (quinone); 9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)-; C10369; 1,3-Dihydroxy-2-hydroxymethylanthraquinoline; ANTHRAQUINONE, 1,3-DIHYDROXY-2-HYDROXYMETHYL-; NSC30546; 4-08-00-03576 (Beilstein Handbook Reference); 478-08-0; HSDB 7146; CCRIS 1642; Lucidin; 1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione; 1,3-Dihydroxy-2-(hydroxymethyl)anthraquinone; NSC 30546; 9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)- (9CI); BRN 1888954; Anthraquinone, 1,3-dihydroxy-2-(hydroxymethyl)-; WLN: L C666 BV IVJ DQ E1Q FQ	C15H10O5	270.24 g/mol	C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)CO)O
TCMBANKIN058851	linalool	Spectrum5_000393; KBioGR_002294; KBio2_003260; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; W263516_ALDRICH; ZINC01529820;beta-linalool;NSC-3789; AK-50127; (+/-)-3,7-Dimethyl-1,6-octadien-3-ol; ACMC-209pf1; D0X5DC; Linalool Solution, 1000 mg/L, 1 ml (RM, ISO GUIDE 34); Linalool, primary pharmaceutical reference standard; CDOSHBSSFJOMGT-UHFFFAOYSA-N; AC1L1MRY; Howood Oil; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3S)-; KSC377K8J; AC1Q1NVD; KB-179981; (+/-) LINALOOL; NCGC00259207-01; 3,6-dien-3-ol; AI3-00942; HSDB 645; (S)-Linalol; 2,7-Octadien-6-ol, 2,6-dimethyl-; 2,6-Dimethylocta-2,7-dien-6-ol; Linalool ex orange oil; (?)-3,7-Dimethyl-1,6-octadien-3-ol; DB-062552; I14-13929; FT-0614785; FCH1115719; Tox21_201658; 11024-20-7; BB_NC-00123; MolPort-001-783-101; LS-97796; 2,6-Dimethyl-2,7-octadien-6-ol; Linalool (natural); L0048; Linalool; BRN 1721488; 2,7-octadiene-6-ol; DSSTox_RID_77812; 3,7-Dimethyl-1,6-octadien-3-ol; BC207603; STL373777; AC1Q2BP3; FEMA No. 2635; ANW-37211; MCULE-2407576698; 3,6-octadien-3-ol; Natural Linalool; Linalool b; SCHEMBL20316; BBL027734; EINECS 204-811-2; LINALOOL (+); CU-01000013132-2; LINOLOOL (D); ST069326; dl-3,7-Dimethyl-3-hydroxy-1,6-octadiene; NSC 3789; CHEBI:17580; Linalool ex ho oil; Linalool, 97%; (.+/-.)-Linalool; allo-Ocimenol; GTPL2469; CCRIS 6557; ( -)-Linalool; BG00600803; NCGC00257060-01; C03985; EINECS 201-134-4; HMS2268E18; Tox21_303037; Phantol; (+-)-Linalool; SBB012353; SMR000112394; DTXSID7025502; (R)-3,7-Dimethyl-1,6-octadien-3-ol; DL -3,7-Dimethyl-3-hydroxy-1,6-octadiene; BB_NC-0123; NCGC00091688-04; (+/-)-3,7-Dimethyl-3-hydroxy-1,6-octadiene; CHEMBL25306; MLS002152908; WLN: 1Y1&U3XQ1&1U1 -,-; LINALYL ALCOHOL; Q-201306; 0-01-00-00462 (Beilstein Handbook Reference); SC-74998; CAS-78-70-6; (+/-)-linalool; LINALOOL EX BOIS DE ROSE; RTR-030706; NCGC00091688-02; Linalool, analytical standard; MFCD00008906; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; Linalool, >=97%, FCC, FG; AC-551; Linolool; NSC3789; Linalool, certified reference material, TraceCERT(R); FEMA Number 2635; AKOS015901617; 3,7-Dimethyl-1, 6-octadien-3-ol; p-Linalool; Linalool ex bois de rose oil; FEMA 2635; DSSTox_CID_5502; .beta.-Linalool; EC 201-134-4; TR-030706; CTK2H7584; LS-1752; KS-00000WLW; 3,7-Dimethylocta-1,6-dien-3-ol; DSSTox_GSID_25502; WLN: 1U1XQ1&3UY1&1; 1,6-Octadien-3-ol, 3,7-dimethyl-; ( )-linalool; CCRIS 3726; Linanool; 78-70-6; NCGC00091688-03; Caswell No. 526A; AN-22986; 2,6-Dimethyl-2,7-octadiene-6-ol; (RS)-Linalool; RP21877; (1)-3,7-Dimethyl-1,6-octadien-3-ol; AN-15757; AC1Q1NVE; LINALOOL, (+-)-; NCGC00091688-01; Linalol; beta-Linalool; EINECS 245-083-6; 22564-99-4; Linalool, .beta.; 2,7-dien-6-ol; EPA Pesticide Chemical Code 128838; 1, 3,7-dimethyl-, (-)-; 3,7-dimethyl-octa-1,6-dien-3-ol;L-linalool;CJ-23937; Spectrum5_000393; LMPR0102010013; AKOS028109218; linalool ; Linalool; 1,6-Octadien-3-ol,3,7-dimethyl-, (3R)-; (R)-3,7-Dimethyl-1,6-octadien-3-ol; AC1L9E4Q; KBioGR_002294; (R)-3,7-dimethylocta-1,6-dien-3-ol; KBio2_003260; Epoxydihydrolinalool; KBio2_000692; (3R)-3,7-dimethylocta-1,6-dien-3-ol; ZINC1529820; Spectrum4_001777; C11388; linalool oxide; 126-91-0; 3U21E3V8I2; KBio3_002285; CCG-38497; CTK8F1408; KBio2_005828; KBioSS_000692; (-)-Linalool; EINECS 204-811-2; (-)-3,7-dimethyl-1,6-octadien-3-ol; LINALOOL (+); (3R)-Linalool; L-LINALOOL, REF. IND.-14<F128><144><F255>; CHEMBL235672; CHEBI:28; SpecPlus_000909; SCHEMBL891312; (-)-Linalool, analytical standard; UNII-3U21E3V8I2; KBio1_001949; J-005448; MolPort-003-666-060; NCGC00095658-01; FT-0772303; BSPBio_002785; SDCCGMLS-0066889.P001; UNII-D81QY6I88E component CDOSHBSSFJOMGT-JTQLQIEISA-N; L-Linalool; 1,6-OCTADIEN-3-OL, 3,7-DIMETHYL-, (-)-; L-Linalool, natural, >=95%, FG; SPBio_002007; Spectrum3_001173; 1,6-Octadien-3-ol, 3,7-dimethyl-, (3R)-; NCGC00095658-02; SPECTRUM1501212; SMP2_000331; (-)-Linalool, >=95.0% (sum of enantiomers, GC); Linalool, (-)-; 3R,7-dimethylocta-1,6-dien-3-ol; DivK1c_007005; (R)-linalool; (R)-(-)-3,7-Dimethyl-1,6-octadien-3-ol; DTXSID40872607; laevo-linalool; MFCD00135469; Spectrum2_001944; I14-45868; (3R)-3,7-dimethyl-1,6-octadien-3-ol; Spectrum_000212; (R)-(-)-Linalool	C10H18O	154.25 g/mol	CC(=CCCC(C)(C=C)O)C
TCMBANKIN059711	beta carotene		C40H56	536.87	CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C
TCMBANKIN059982	d-limonene		C10H16	136.23 g/mol	CC1=CCC(CC1)C(=C)C
TCMBANKIN060026	δ-carotene		C40H56	536.87	CC1=CCCC(C1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C)C)C)(C)C
TCMBANKIN060290	Galgravin;di-o-methyltetrahydrofuriguaiacin b;(?)-galbelgin;saucernetin;(±)-galgravin;Veraguensin;(+)-galbelgin		C22H28O5	372.45	CC1C(C(OC1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C
TCMBANKIN060677	alpha-spinasteryl-β-d-glucoside				CCC(C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C
TCMBANKIN060900	Nonane, 3-methyl-		C10H22	142.28 g/mol	CCCCCCC(C)CC
TCMBANKIN061424	glutaric acid methylester	KB-246388; Tox21_301438; MolPort-001-791-781; KSC175I8R; MCULE-9458960872; CCG-37764; NSC-93807; NCGC00013981-02; monomethyl glutaric acid; Glutaric Acid Monomethyl Ester; EINECS 216-116-1; Glutaric acid 1-methyl ester; NCI60_042093; J-008660; Monomethyl ester of glutarate; glutaric acid mono methyl ester; 4-Carboxybutanoic acid methyl ester; 4-(Methoxycarbonyl)butyric acid; AKOS000278803; MFCD00004409; NCIStruc2_000094; KS-00000GMQ; Glutaric acid methyl ester; Methyl hydrogen glutarate; CHEBI:86396; 4-(methoxycarbonyl)butanoic acid; METHYL HYDROGEN PENTANE-1,5-DIOATE; 1501-27-5; NCGC00097090-01; NCGC00255716-01; 5-methoxy-5-oxopentanoic acid; Monomethyl ester of glutaric acid; DSSTox_GSID_44589; ANW-21254; 4-(Methoxycarbonyl)butyrate; Monomethyl glutarate; TIMTEC-BB SBB007943; FT-0626734; AS01329; FR-0632; CTK0H5488; 5-Methoxy-5-oxopentanoic acid; SCHEMBL19772; CAS-1501-27-5; DSSTox_RID_80335; 5-(methyloxy)-5-oxopentanoic acid; G0258; methyl glutarate; 5-Methoxy-5-oxopentanoic acid #; 4-Carboxybutanoic acid; Glutaric acid, monomethyl ester; Methyl hydrogen glutrate; Pentanedioic acid, 1-methyl ester; TR-006112; mono-Methyl glutarate, 95%; 5-keto-5-methoxy-valeric acid; Glutaric acid, monomethyl ester (8CI); DSSTox_CID_24589; UNII-SK94163098; SC-85837; IBMRTYCHDPMBFN-UHFFFAOYSA-N; Glutaric acid methyl half ester; 4-Methoxycarbonylbutanoate; NCIStruc1_001792; Pentanedioic acid monomethyl ester; ST24029506; PENTANEDIOIC ACID, MONOMETHYL ESTER; AS-10521; RTR-006112; 5-methoxy-5-oxo-pentanoic acid; Z1592032314; ZINC1609498; NCI93807; 7511AA; RL01916; 4-Methoxycarbonylbutanoic acid; AIDS017707; AC1Q442T; NSC 93807; AN-49340; CHEMBL1483438; NSC93807; Methyl glutarate,mono; AK-76606; AC1L2KSS; SK94163098; SBB007943; Glutaric acid monomethylester; AM84460; DTXSID4044589; NE10313; AC1Q5VYW; I04-1022; mono-Methyl glutarate; AIDS-017707; AJ-28198; M47353_ALDRICH; NCGC00013981; Methyl glutarate (VAN); Methyl glutarate	C6H10O4	146.14 g/mol	COC(=O)CCCC(=O)O
TCMBANKIN061658	(-)-methylnissolin;methylnissolin	methylnissolin	C17H16O5	300.3 g/mol	COC1=C(C2=C(C=C1)C3COC4=C(C3O2)C=CC(=C4)O)OC
TCMBANKIN061753	tricin	5,7,4′-Trihydroxy-3′,5′-dimethoxyflavone; NSC294579; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-chromenone; AIDS-120640; 3',5'-O-dimethyltricetin; CHEBI:60016; 3',5'-di-O-methyltricetin(1-); 5,7,4-trihydroxy-3, 5-dimethoxyflavone; 3',5'-di-O-methyltricetin; 520-32-1; Tricetin 3',5'-di-methyl ether; Tricin; C10193; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-4-one; 5,7-Dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-1-benzopyran-4-one; AIDS120640; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)chromen-4-one; NSC 294579; 4',5,7-trihydroxy-3',5'-dimethoxyflavone; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)chromone; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4-oxo-4H-chromen-7-olate	C17H14O7	330.29	COC1=CC(=CC(=C1O)OC)C2=CC(=O)C3=C(C=C(C=C3O2)O)O
TCMBANKIN061754	tricin- 7- O- β- D- glucoside	tricin-7-O-β-D-glucoside; tricin-7-o-beta-d-glucoside; tricin-7-o-beta-d-glucoside; Tricin 7-O-glucopyranoside; tricin-7-o-β-d-glucopyranoside; Tricin-7-O-beta-D-glucopyranoside; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; 5-hydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone; tricin-7-o-beta-d-glucopyranoside	C23H24O12	492.4 g/mol	COC1=CC(=CC(=C1O)OC)C2=CC(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O
TCMBANKIN061903	methyl d-galactoside	.beta.-d-Methylglucopyranoside; Methyl b-D-glucopyranoside; (2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol; DB-055468; 709-50-2; FT-0628705; 75398-85-5; 7804AF; NSC 403457; beta-d-Methylglucopyranoside; CHEMBL132186; methyl beta-(D)-glucopyranoside; UNII-54L5T38NI8 component HOVAGTYPODGVJG-XUUWZHRGSA-N; CM-1331; Methyl beta-d-glucopyranoside hemihydrate; Methyl .beta.-D-glucoside; beta-Methyl-D-glucoside hemihydrate; CHEBI:320055; 27939-29-3; BG01510468; KS-000007XU; DB01642; beta-Methylglucoside; Glucopyranoside, methyl, .beta.-D-; Methyl beta-D-glucopyranoside, >=99% (HPLC and GC); M0779_SIGMA; EINECS 211-909-9; BIM8001; Methyl-beta-D-glucopyranoside hemihydrate, >=99.0% (sum of enantiomers, HPLC); Methyl b-D-glucopyranoside hemihydrate; TL8006618; 1-O-Methyl-beta-D-glucopyranoside; Epitope ID:149560; beta-Methyl-D-glucoside; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol; 30326-25-1; 7000-27-3; SCHEMBL166332; MGL; 709-50-2 Methyl beta-d-glucopyranosi de; METHYL ?-D-GLUCOSIDE; C-30724; M0709; FT-0628867; MFCD00149442; O1-Methyl-Glucose; HT1198; 1-O-methyl-beta-D-glucopyranose; W-200489; AJ-49843; Methyl beta-D-glucoside hydrate; 1-O-Methyl-.beta.-D-glucopyranoside; Methyl beta-D-glucopyranoside; GC7084; β-methyl-d-glucoside; b-methyl-D-glucoside; 97-30-3; methyl -d-glucopyranoside; Methyl beta-D-glucoside; CC-30725; FCH920155; Methyl-alpha-D-glucopyranoside; Me-ss-Glc; ZX-AFC000308; .beta.-Methyl-(d)-glucoside; AKOS006343694; Methyl b-D-glucoside; beta-D-Glucopyranoside, methyl; HOVAGTYPODGVJG-XUUWZHRGSA-N; Methyl-b-D-glucopyranoside hemihydrate; AK481297; ZINC4262103; Methyl--D-glucoside hemihydrate; MFCD00006602; Methyl-beta-D-glucoside; Methyl .beta.-D-glucopyranoside; Methyl-beta-D-glucopyranoside; methyl-beta-D-glucopyranoside hemihydrate; AC1L9HNF;beta-methyl-d-glucoside;(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxytetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxy-tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxy-oxane-3,4,5-triol; 66950_FLUKA; O1-METHYL-GLUCOSE; (2R,3R,4S,5S,6R)-2-methoxy-6-methylol-tetrahydropyran-3,4,5-triol; beta-Methyl-D-glucoside; Methyl-beta-D-glucopyranoside; M0779_SIGMA; ZINC04262103; 7000-27-3; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;MGL;1-O-methyl-α-D-cymadropyranoside	C7H14O6	194.18 g/mol	COC1C(C(C(C(O1)CO)O)O)O

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型

TCMBank_ID:

TCMBANKHE003919

ID:

TCMBANKHE003919

植物拉丁名:

Medicago sativa

功能与主治:

To clear heat and cool blood, disinhibit damp and abate jaundice./Febrile diseases with vexation and fullness, jaundice, enteritis, dysentery, edema, urethral stone, hematochezia from hemorrhoids.

药用植物名:

苜蓿

药用部位:

whole herb

TCM_ID_id:

5759